Paper34740322
NOX4-derived ROS-induced overexpression of FOXM1 regulates aerobic glycolysis in glioblastoma.
Su X and 9 others. BMC Cancer, 2021. Cited by 37 papers, by iCite.
Cite this record
ConductScience Library. NOX4-derived ROS-induced overexpression of FOXM1 regulates aerobic glycolysis in glioblastoma. Papers, record 34740322. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34740322
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- NOX4-derived ROS-induced overexpression of FOXM1 regulates aerobic glycolysis in glioblastoma.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain Neoplasms | Major topic |
| Forkhead Box Protein M1 | Major topic |
| Glioblastoma | Major topic |
| NADPH Oxidase 4 | Major topic |
| Reactive Oxygen Species | Major topic |
| Warburg Effect, Oncologic | Major topic |
| Adenosine Triphosphate | |
| Animals | |
| Blotting, Western | |
| Brain | |
| Cell Line, Tumor | |
| Humans | |
| Hypoxia-Inducible Factor 1, alpha Subunit | |
| Lactic Acid | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Nude | |
| Mitochondria | |
| Neoplasm Proteins | |
| Neoplasm Transplantation |
Source PubMed
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32411237 | Targeted Molecular Therapy in Glioblastoma. | J Oncol | 2020 | https://conductscience.org/library/papers/32411237 | PubMed |
| 2 | 32174012 | Long noncoding RNA SLC2A1-AS1 regulates aerobic glycolysis and progression in hepatocellular carcinoma via inhibiting the STAT3/FOXM1/GLUT1 pathway. | Mol Oncol | 2020 | https://conductscience.org/library/papers/32174012 | PubMed |
| 3 | 21242296 | Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme. | J Exp Med | 2011 | https://conductscience.org/library/papers/21242296 | PubMed |
| 4 | 28587975 | ROS signalling in the biology of cancer. | Semin Cell Dev Biol | 2018 | https://conductscience.org/library/papers/28587975 | PubMed |
| 5 | 24298908 | Tumor glycolysis as a target for cancer therapy: progress and prospects. | Mol Cancer | 2013 | https://conductscience.org/library/papers/24298908 | PubMed |
| 6 | 26180081 | Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions. | Neuro Oncol | 2016 | https://conductscience.org/library/papers/26180081 | PubMed |
| 7 | 27989748 | NOX4 supports glycolysis and promotes glutamine metabolism in non-small cell lung cancer cells. | Free Radic Biol Med | 2016 | https://conductscience.org/library/papers/27989748 | PubMed |
| 8 | 18508317 | Enhanced expression of NADPH oxidase Nox4 in human gliomas and its roles in cell proliferation and survival. | Int J Cancer | 2008 | https://conductscience.org/library/papers/18508317 | PubMed |
| 9 | 24634381 | FOXM1 promotes the warburg effect and pancreatic cancer progression via transactivation of LDHA expression. | Clin Cancer Res | 2014 | https://conductscience.org/library/papers/24634381 | PubMed |
| 10 | 28088622 | Reactive oxygen species and cancer paradox: To promote or to suppress? | Free Radic Biol Med | 2017 | https://conductscience.org/library/papers/28088622 | PubMed |
| 11 | 26297045 | Reactive oxygen species production has a critical role in hypoxia-induced Stat3 activation and angiogenesis in human glioblastoma. | J Neurooncol | 2015 | https://conductscience.org/library/papers/26297045 | PubMed |
| 12 | 34257808 | NOX4-Derived ROS Mediates TGF-β1-Induced Metabolic Reprogramming during Epithelial-Mesenchymal Transition through the PI3K/AKT/HIF-1α Pathway in Glioblastoma. | Oxid Med Cell Longev | 2021 | https://conductscience.org/library/papers/34257808 | PubMed |
| 13 | 19696738 | FoxM1, a critical regulator of oxidative stress during oncogenesis. | EMBO J | 2009 | https://conductscience.org/library/papers/19696738 | PubMed |
| 14 | 28855104 | FoxM1: Repurposing an oncogene as a biomarker. | Semin Cancer Biol | 2018 | https://conductscience.org/library/papers/28855104 | PubMed |
| 15 | 21376230 | Hallmarks of cancer: the next generation. | Cell | 2011 | https://conductscience.org/library/papers/21376230 | PubMed |
| 16 | 32478924 | Management of glioblastoma: State of the art and future directions. | CA Cancer J Clin | 2020 | https://conductscience.org/library/papers/32478924 | PubMed |
| 17 | 21985671 | Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. | Annu Rev Cell Dev Biol | 2011 | https://conductscience.org/library/papers/21985671 | PubMed |
| 18 | 31072351 | FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression. | J Exp Clin Cancer Res | 2019 | https://conductscience.org/library/papers/31072351 | PubMed |
| 19 | 22689530 | A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo. | Mol Cancer Ther | 2012 | https://conductscience.org/library/papers/22689530 | PubMed |
| 20 | 32697943 | Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis. | Cell Metab | 2020 | https://conductscience.org/library/papers/32697943 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42737836 | Redox Regulation in Glioblastoma: Mechanisms, Biomarkers, and Therapeutic Implications. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737836 | PubMed |
| 42350727 | Research progress on the expression characteristics, biological functions, and therapeutic potential of NOX4 in malignant tumors: a functional perspective. | Clin Transl Oncol | 2026 | https://conductscience.org/library/papers/42350727 | PubMed |
| 41655237 | Mitochondrial CircRNA CircMT-RNR2 Safeguards Antioxidant Defense to Support Fibroblast Functions in Wound Repair. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41655237 | PubMed |
| 41373022 | Mitochondria at the intersections of RNA modifications and metabolism reprogramming implications in cell death, tumor microenvironment, and immunotherapy. | J Hematol Oncol | 2025 | https://conductscience.org/library/papers/41373022 | PubMed |
| 41244121 | The oxidative modification of transcription factor FOXM1 by Peroxiredoxin1 facilitates DNA damage repair and cancer progression. | Am J Cancer Res | 2025 | https://conductscience.org/library/papers/41244121 | PubMed |
| 41096582 | Organophosphate Chemical Nerve Agents, Oxidative Stress, and NADPH Oxidase Inhibitors: An Overview. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41096582 | PubMed |
| 40962327 | AQP1/4, CLIC5 dysregulation and lipid metabolism alterations in lung cancer. | BMB Rep | 2026 | https://conductscience.org/library/papers/40962327 | PubMed |
| 40681642 | Prostate cancer cell-derived exosomes inhibit macrophage phagocytosis through EIF3B-mediated exosomal sorting of miR-100-5p. | Sci Rep | 2025 | https://conductscience.org/library/papers/40681642 | PubMed |
| 40605162 | A Gene Signature Developed Based on Reactive Oxygen Species to Predict the Metabolism, Immunity, Mutational Status, and Prognostic Survival for Glioblastoma. | Curr Med Chem | 2025 | https://conductscience.org/library/papers/40605162 | PubMed |
| 40314087 | Deuterium-depleted water inhibits the malignant progression of colorectal cancer cells by modulating oxidative stress. | Oncol Rep | 2025 | https://conductscience.org/library/papers/40314087 | PubMed |
| 39430321 | TRIM27 revealing by tumor educated platelet RNA-sequencing, as a potential biomarker for malignant ground-glass opacities diagnosis mediates glycolysis of non-small cell lung cancer cells partially through HOXM1. | Transl Lung Cancer Res | 2024 | https://conductscience.org/library/papers/39430321 | PubMed |
| 38756075 | Structure-Based Virtual Screening of Novel FOXM1 Inhibitors as Potential Compounds for Glioblastoma Treatment. | Recent Pat Anticancer Drug Discov | 2025 | https://conductscience.org/library/papers/38756075 | PubMed |
| 37821870 | Forkhead box transcription factors (FOXOs and FOXM1) in glioma: from molecular mechanisms to therapeutics. | Cancer Cell Int | 2023 | https://conductscience.org/library/papers/37821870 | PubMed |
| 37670970 | NOX4-derived ROS Regulates Aerobic Glycolysis of Breast Cancer through YAP Pathway. | J Cancer | 2023 | https://conductscience.org/library/papers/37670970 | PubMed |
| 37371958 | Role of NADPH Oxidase 4 in Corneal Endothelial Cells Is Mediated by Endoplasmic Reticulum Stress and Autophagy. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/37371958 | PubMed |
| 37183806 | Neutralization of Intracellular pH Homeostasis to Inhibit Osteoclasts Based on a Spatiotemporally Selective Delivery System. | Nano Lett | 2023 | https://conductscience.org/library/papers/37183806 | PubMed |
| 36768405 | NOX Dependent ROS Generation and Cell Metabolism. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36768405 | PubMed |
| 36505747 | Structure-based virtual screening identified novel FOXM1 inhibitors as the lead compounds for ovarian cancer. | Front Chem | 2022 | https://conductscience.org/library/papers/36505747 | PubMed |
| 36407005 | Mutual regulation of lactate dehydrogenase and redox robustness. | Front Physiol | 2022 | https://conductscience.org/library/papers/36407005 | PubMed |
| 36281949 | Regulators of epigenetic change in ferroptosis‑associated cancer (Review). | Oncol Rep | 2022 | https://conductscience.org/library/papers/36281949 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CCNB1 | 891 | PubTator's text mining | https://conductscience.org/library/genes/891 | NCBI Gene |
| CCND1 | 595 | PubTator's text mining | https://conductscience.org/library/genes/595 | NCBI Gene |
| FOXM1 | 2305 | PubTator's text mining | https://conductscience.org/library/genes/2305 | NCBI Gene |
| HIF1A | 3091 | PubTator's text mining | https://conductscience.org/library/genes/3091 | NCBI Gene |
| HK2 | 3099 | PubTator's text mining | https://conductscience.org/library/genes/3099 | NCBI Gene |
| LDHA | 3939 | PubTator's text mining | https://conductscience.org/library/genes/3939 | NCBI Gene |
| NOX4 | 50507 | PubTator's text mining | https://conductscience.org/library/genes/50507 | NCBI Gene |
| PLK1 | 5347 | PubTator's text mining | https://conductscience.org/library/genes/5347 | NCBI Gene |
| SLC2A1 | 6513 | PubTator's text mining | https://conductscience.org/library/genes/6513 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34740322
GET https://conductscience.org/api/papers/v1/34740322/references?page=2